Rosamaria Pinto

960 citations

28 papers · 655 indexed · h-index 16

Co-authors: Stefania Tommasi Simona De Summa Brunella Pilato Rosanna Lacalamita Daniela Petriella Katia Danza Angelo Paradiso Simona Serratì
Topics: Melanoma and MAPK Pathways (6 papers)BRCA gene mutations in cancer (5 papers)Epigenetics and DNA Methylation (4 papers)
Cited by: Cancer Research Molecular Biology Oncology
Journals: PLoS ONE American Journal of Respiratory and Critical Care Medicine Frontiers in Immunology
Partner nations: Italy Romania

In The Last Decade

Rosamaria Pinto

28 papers receiving 647 citations

Peers

Countries citing papers authored by Rosamaria Pinto

Since Specialization

Citations

This map shows the geographic impact of Rosamaria Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosamaria Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosamaria Pinto more than expected).

Fields of papers citing papers by Rosamaria Pinto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosamaria Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosamaria Pinto. The network helps show where Rosamaria Pinto may publish in the future.

Co-authorship network of co-authors of Rosamaria Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Rosamaria Pinto. A scholar is included among the top collaborators of Rosamaria Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosamaria Pinto. Rosamaria Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma? 2024 ·Frontiers in Immunology ·(unknown),(unknown),Benedetta Apollonio,Livia Fucci,(unknown),Michele Rossi,Rosamaria Pinto,Stefania Tommasi,(unknown),Sabino Strippoli,Michele Guida	2
2	The Genetic Germline Background of Single and Multiple Primary Melanomas 2021 ·Frontiers in Molecular Biosciences ·Simona De Summa,(unknown),Sabino Strippoli,Giuseppe Giudice,Gabriella Guida,Rossella Elia,Eleonora Nacchiero,Amalia Azzariti,Nicola Silvestris,Michele Guida,Stefania Guida,Stefania Tommasi,Rosamaria Pinto	6
3	miRNAs as Key Players in the Management of Cutaneous Melanoma 2020 ·Cells ·(unknown),Simona De Summa,Rosamaria Pinto,Katia Danza,Stefania Tommasi	24
4	Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 2020 ·Frontiers in Oncology ·Umberto Malapelle,Francesco Pepe,Pasquale Pisapia,Roberta Sgariglia,Mariantonia Nacchio,Caterina De Luca,Rosanna Lacalamita,Stefania Tommasi,Rosamaria Pinto,Grazia Palomba,Giuseppe Palmieri,Davide Vacirca,Massimo Barberis,Irene Bottillo,Paola Grammatico,(unknown),Valerio Costa,(unknown),Dario Bruzzese,Giancarlo Troncone	9
5	The search for a melanoma-tailored chemotherapy in the new era of personalized therapy: a phase II study of chemo-modulating temozolomide followed by fotemustine and a cooperative study of GOIM (Gruppo Oncologico Italia Meridionale) 2018 ·BMC Cancer ·Michele Guida,Stefania Tommasi,Sabino Strippoli,(unknown),Simona De Summa,Rosamaria Pinto,(unknown),(unknown),Salvatore Pisconti,Michele Aieta,(unknown),Amalia Azzariti,Gabriella Guida,Vito Lorusso,(unknown)	16
6	GATK hard filtering: tunable parameters to improve variant calling for next generation sequencing targeted gene panel data 2017 ·BMC Bioinformatics ·Simona De Summa,Giovanni Malerba,Rosamaria Pinto,Antonio Mori,Vladan Mijatovic,Stefania Tommasi	71
7	Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients 2017 ·Oncology Letters ·Simona De Summa,Francesca Graziano,Brunella Pilato,Rosamaria Pinto,Katia Danza,Rosanna Lacalamita,Simona Serratì,D. Sambiasi,Mario Grassi,Stefania Tommasi	2
8	Next-generation sequencing: advances and applications in cancer diagnosis 2016 ·OncoTargets and Therapy ·Simona Serratì,Simona De Summa,Brunella Pilato,Daniela Petriella,Rosanna Lacalamita,Stefania Tommasi,Rosamaria Pinto	140
9	miR-151-5p, targeting chromatin remodeler SMARCA5, as a marker for the BRCAness phenotype 2016 ·Oncotarget ·Stefania Tommasi,Rosamaria Pinto,Katia Danza,Brunella Pilato,Orazio Palumbo,Lucia Micale,Simona De Summa	19
10	The next generation of metastatic melanoma: uncovering the genetic variants for anti-BRAF therapy response 2016 ·Oncotarget ·Rosamaria Pinto,Simona De Summa,Sabino Strippoli,Brunella Pilato,Amalia Azzariti,Gabriella Guida,Michele Guida,Stefania Tommasi	6
11	MicroRNA expression in BRAF-mutated and wild-type metastatic melanoma and its correlation with response duration to BRAF inhibitors 2015 ·Expert Opinion on Therapeutic Targets ·Rosamaria Pinto,Sabino Strippoli,Simona De Summa,(unknown),Amalia Azzariti,Gabriella Guida,Ondina Popescu,Vito Lorusso,Michele Guida,Stefania Tommasi	25
12	Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation 2014 ·PLoS ONE ·Vito Michele Garrisi,Sabino Strippoli,Simona De Summa,Rosamaria Pinto,(unknown),Gabriella Guida,Amalia Azzariti,Michele Guida,Stefania Tommasi	13
13	MiR-578 and miR-573 as potential players in BRCA-related breast cancer angiogenesis 2014 ·Oncotarget ·Katia Danza,Simona De Summa,Rosamaria Pinto,Brunella Pilato,Orazio Palumbo,Giuseppe Merla,Gianni Simone,Stefania Tommasi	48
14	Combined microRNA and ER expression: a new classifier for familial and sporadic breast cancer patients 2014 ·Journal of Translational Medicine ·Katia Danza,Simona De Summa,Brunella Pilato,Massimo Carella,Orazio Palumbo,Ondina Popescu,Angelo Paradiso,Rosamaria Pinto,Stefania Tommasi	9
15	The value of new high-throughput technologies for diagnosis and prognosis in solid tumors 2014 ·Cancer Biomarkers ·Rosamaria Pinto,Simona De Summa,Daniela Petriella,Oana Tudoran,Katia Danza,Stefania Tommasi	15
16	Different methylation and MicroRNA expression pattern in male and female familial breast cancer 2012 ·Journal of Cellular Physiology ·Rosamaria Pinto,Brunella Pilato,Laura Ottini,(unknown),Giovanni de Simone,Angelo Paradiso,Stefania Tommasi	32
17	HOX gene methylation status analysis in patients with hereditary breast cancer 2012 ·Journal of Human Genetics ·Brunella Pilato,Rosamaria Pinto,Simona De Summa,(unknown),Angelo Paradiso,Stefania Tommasi	28
18	Oncosuppressor methylation: A possible key role in colon metastatic progression 2010 ·Journal of Cellular Physiology ·Stefania Tommasi,Rosamaria Pinto,Daniela Petriella,Brunella Pilato,Rosanna Lacalamita,Daniele Santini,Francesco Alfredo Zito,Giuseppe Colucci,Angelo Paradiso,Nicola Silvestris	16
19	Molecular and in silico analysis of BRCA1 and BRCA2 variants 2008 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·Stefania Tommasi,Brunella Pilato,Rosamaria Pinto,Alessandro Monaco,(unknown),Marco Campana,Maria Digennaro,Francesco Schittulli,Rosanna Lacalamita,Angelo Paradiso	34
20	3p Microsatellite Signature in Exhaled Breath Condensate and Tumor Tissue of Patients with Lung Cancer 2007 ·American Journal of Respiratory and Critical Care Medicine ·Giovanna Elisiana Carpagnano,Maria Pia Foschino Barbaro,Antonio Spanevello,Onofrio Resta,Francesco Carpagnano,Giuseppina Mulè,Rosamaria Pinto,Stefania Tommasi,Angelo Paradiso	55

About Rosamaria Pinto

Rosamaria Pinto is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 28 papers that have together received 655 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), BRCA gene mutations in cancer (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (274 citations), Molecular Biology (408 citations) and Oncology (128 citations). Rosamaria Pinto has collaborated with scholars based in Italy and Romania. Frequent co-authors include Stefania Tommasi, Simona De Summa, Brunella Pilato, Rosanna Lacalamita, Daniela Petriella, Katia Danza, Angelo Paradiso, Simona Serratì, Antonio Mori and Vladan Mijatovic. Their work appears in journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact